Cooper J, Giancotti FG. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 2019;35(3):347–67.
CAS PubMed PubMed Central Article Google Scholar
Hu Y-Z, Hu Z-L, Liao T-Y, et al. LncRNA SND1-IT1 facilitates TGF-β1-induced epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in gastric cancer. Cell death discovery. 2022;8(1):1–12.
Liu K, Cheng L, Zhu K, et al. The cancer/testis antigen HORMAD1 mediates epithelial–mesenchymal transition to promote tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway in lung cancer. Cell Death Discovery. 2022;8(1):1–14.
Hu Z, Artibani M, Alsaadi A, et al. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell. 2020;37(2):226-242 e7.
CAS PubMed Article Google Scholar
Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int. 2021;45(2):273–86.
CAS PubMed Article Google Scholar
Mortezaee K. Organ tropism in solid tumor metastasis: an updated review. Future Oncol. 2021. https://doi.org/10.1002/cbin.11506.
Bhattacharya A, Mukherjee S, Khan P, et al. SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin. Sci Signal. 2020;13(654):eaay6077.
CAS PubMed Article Google Scholar
Farhood B, Najafi M, Salehi E, et al. Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy. J Cell Biochem. 2019;120(1):71–6.
CAS PubMed Article Google Scholar
Mortezaee K, Majidpoor J. Key promoters of tumor hallmarks. Int J Clin Oncol. 2021;27:45–58.
PubMed Article CAS Google Scholar
Zou H, Yang Z, Chan Y-S, et al. Single cell analysis of mechanical properties and EMT-related gene expression profiles in cancer fingers. Iscience. 2022;25(3):103917.
CAS PubMed PubMed Central Article Google Scholar
Okita Y, Kimura M, Xie R, et al. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB. Sci Signal. 2017;10(474):eaak9397.
PubMed Article CAS Google Scholar
Chang Y, Zhang J, Huo X, et al. Substrate rigidity dictates colorectal tumorigenic cell stemness and metastasis via CRAD-dependent mechanotransduction. Cell Rep. 2022;38(7):110390.
CAS PubMed Article Google Scholar
Majidpoor J, Mortezaee K. Steps in metastasis: an updated review. Med Oncol. 2021;38(1):1–17.
Mortezaee K, Majidpoor J. (Im) maturity in tumor ecosystem. Front Oncol. 2021;11:813897–813897.
Chakraborty S, Mir KB, Seligson ND, et al. Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis. Cancer Metastasis Rev. 2020. https://doi.org/10.1007/s10555-020-09866-x.
Cano A, Pérez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2(2):76–83.
CAS PubMed Article Google Scholar
Chakrabarti R, Hwang J, Andres Blanco M, et al. Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol. 2012;14(11):1212–22.
CAS PubMed PubMed Central Article Google Scholar
Serresi M, Kertalli S, Li L, et al. Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition. Sci Adv. 2021;7(9):eabd7974.
CAS PubMed PubMed Central Article Google Scholar
Wu L, Yu K, Chen K, et al. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death Dis. 2022;13(3):1–12.
Liu J, Zang Y, Ma C, et al. Pseudophosphatase STYX is induced by Helicobacter pylori and promotes gastric cancer progression by inhibiting FBXO31 function. Cell Death Dis. 2022;13(3):1–12.
Yao Y, Liu Z, Huang S, et al. The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway. Cell Death Discov. 2022;8(1):1–12.
Mortezaee K. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer. J Biochem Mol Toxicol. 2021;35(4):e22708.
CAS PubMed Article Google Scholar
Li Y, Hu J, Guo D, et al. LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway. Cancer Gene Ther. 2022. https://doi.org/10.1038/s41417-022-00456-3.
Article PubMed PubMed Central Google Scholar
Hermann PC, Sainz B Jr. Pancreatic cancer stem cells: A state or an entity? in Seminars in cancer biology. Amsterdam: Elsevier; 2018.
Kim J, Park C, Kim KH, et al. Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity. NPJ Precis Oncol. 2022;6(1):1–11.
Nicolas AM, Pesic M, Engel E, et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. Cancer Cell. 2022;40(2):168-184 e13.
CAS PubMed Article Google Scholar
Najafi M, Mortezaee K, Majidpoor J. Stromal reprogramming: a target for tumor therapy. Life Sci. 2019;239:117049.
CAS PubMed Article Google Scholar
Boukouris AE, Zhang Y, Saleme B, et al. A reversible metabolic stress-sensitive regulation of CRMP2A orchestrates EMT/stemness and increases metastatic potential in cancer. Cell Rep. 2022;38(11):110511.
CAS PubMed Article Google Scholar
Li H, Li J, Chen L, et al. HERC3-mediated SMAD7 ubiquitination degradation promotes autophagy-induced EMT and chemoresistance in glioblastoma. Clin Cancer Res. 2019;25(12):3602–16.
CAS PubMed Article Google Scholar
Wilson MM, Callens C, Le Gallo M, et al. An EMT–primary cilium–GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis. Sci Adv. 2021;7(44):eabf6063.
CAS PubMed PubMed Central Article Google Scholar
García-Jiménez C, Goding CR. Starvation and pseudo-starvation as drivers of cancer metastasis through translation reprogramming. Cell Metab. 2019;29(2):254–67.
PubMed Article CAS Google Scholar
Liu M, Li H, Zhang H, et al. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Cell Death Dis. 2022;13(3):1–12.
Majidpoor J, Mortezaee K. Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications. Biomed Pharmacother. 2022;145:112419.
CAS PubMed Article Google Scholar
Li L, Li Z, Lu C, et al. Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling. Commun Biolo. 2022;5(1):1–14.
Brodziak A, Sobczuk P, Bartnik E, et al. Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities. Nat Rev Urol. 2019;16(11):655–73.
Qi M, Xia Y, Wu Y, et al. Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression. Nat Commun. 2022;13(1):1–18.
Xia X, Zhang Z, Zhu C, et al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun. 2022;13(1):1–14.
Stehr AM, Wang G, Demmler R, et al. Neutrophil extracellular traps drive epithelial–mesenchymal transition of human colon cancer. J Pathol. 2022;256(4):455–67.
CAS PubMed Article Google Scholar
Majidpoor J, Mortezaee K. The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives. Clin Immunol. 2021;226:108707.
CAS PubMed Article Google Scholar
Mortezaee K, Majidpoor J. Checkpoint inhibitor/interleukin-based combination therapy of cancer. Cancer Med. 2022. https://doi.org/10.1002/cam4.4659.
Article PubMed PubMed Central Google Scholar
Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338-354 e15.
CAS PubMed PubMed Central Article Google Scholar
Ricklefs FL, Alayo Q, Krenzlin H, et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci Adv. 2018;4(3):eaar2766.
PubMed PubMed Central Article CAS Google Scholar
Guo Y, Lu X, Chen Y, et al. Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells. Sci Adv. 2021;7(21):eabd7455.
留言 (0)